EDOC


Telemedicine & Digital Health ETF

Reasons to Consider EDOC

High Growth Potential

The global telemedicine market increased over 6% from 2021 to 2022, exceeding $75bn. Forecasts suggest the market could reach over $200bn by 2027.1

Structural Tailwinds

In 2019, an estimated half of the global population lacked essential health care services.2 As more underserved markets gain broadband access, telemedicine offers vast opportunity to bridge the divide.

New Consumer Preferences

The pandemic increased adoption of digital health services, with many turning to telemedicine for the first time, accelerating the theme’s reach.

1Statista, Dec 2022
2World Economic Forum

Key Information As of 09/22/23

Inception Date 07/29/20
Total Expense Ratio 0.68%
Net Assets $88.14 million
NAV $9.12
Fact Sheet View the document

ETF Summary

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to invest in companies positioned to benefit from further advances in the field of telemedicine and digital health. This includes companies involved in Telemedicine, Health Care Analytics, Connected Health Care Devices, and Administrative Digitization.

ETF Objective

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index.

Trading Details As of 09/21/23

Ticker EDOC
Bloomberg Index Ticker SOLEDOC
CUSIP 37954Y285
ISIN US37954Y2853
Primary Exchange Nasdaq
Shares Outstanding 9,660,000
Number of Holdings 41
30-Day Median Bid-Ask Spread 0.73%

Distributions As of 09/22/23

30-Day SEC Yield 0.09%
Distribution Frequency Semi-Annually

ETF Prices As of 09/22/23

NAV $9.12 Daily Change -$0.01 -0.11%
Market Price $9.12 Daily Change $0.00 0.00%

Performance History

As of recent
(06/30/23)
As of recent
(06/30/23)
Fund NAV Market Price Index
1 Year 1.04% 0.95% 1.19%
Since Inception -8.73% -8.81% -8.35%
1 Year -15.58% -15.43% -15.48%
3 Years -13.99% -13.98% -13.61%
Since Inception -11.74% -11.71% -11.36%
Year-to-Date -0.17% 0.43% -0.30%
1 Month 4.67% 4.77% 4.71%
3 Months -1.10% -0.77% -0.98%
Since Inception -23.42% -23.61% -22.47%
Year-to-Date -11.39% -10.54% -11.42%
1 Month -13.97% -13.59% -13.92%
3 Months -7.09% -6.67% -6.96%
Since Inception -32.02% -31.95% -31.11%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 09/22/23

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
5.15 RCM R1 RCM INC BP2S437 15.58 288,523 4,495,188.34
4.82 AMN AMN HEALTHCARE 2813552 82.47 51,008 4,206,629.76
4.66 LH LABORATORY CP 2586122 205.15 19,804 4,062,790.60
4.51 PACB PACIFIC BIOSCIEN B4N8MH9 8.94 440,165 3,935,075.10
4.25 OMCL OMNICELL INC 2789523 49.82 74,361 3,704,665.02
4.21 A AGILENT TECHNOLOGIES INC 2520153 111.41 32,988 3,675,193.08
4.21 241 HK ALIBABA HEALTH BRXVS60 0.60 6,117,100 3,668,273.34
4.15 PRVA PRIVIA HEALTH GROUP INC BMDP209 21.63 167,227 3,617,120.01
3.79 VCYT VERACYTE INC BFTWZY0 22.47 147,137 3,306,168.39
3.75 6618 HK JD HEALTH BMW8R04 5.33 614,750 3,273,835.17
3.67 TDOC TELADOC HEALTH INC BYQRFY1 18.78 170,273 3,197,726.94
3.53 DXCM DEXCOM INC B0796X4 87.50 35,181 3,078,337.50
3.18 IRTC IRHYTHM TECHNOLOGIES INC BYT4ST5 85.50 32,474 2,776,527.00
3.16 ILMN ILLUMINA INC 2613990 132.44 20,825 2,758,063.00
3.16 MDRX VERADIGM INC 2710039 12.62 218,303 2,754,983.86
3.11 RMD AU RESMED INC-CDI 6221667 13.95 194,620 2,715,855.98
2.97 NXGN NEXTGEN HEALTHCARE INC BF5L3D6 23.65 109,347 2,586,056.55
2.86 1833 HK PING AN HEALTHCA BDRYVB3 2.34 1,066,900 2,496,422.41
2.81 DOCS DOXIMITY INC-CLASS A BMD22Y4 19.89 123,248 2,451,402.72
2.76 TNDM TANDEM DIABETES CARE INC BF3W461 20.59 116,881 2,406,579.79
2.63 TWST TWIST BIOSCIENCE CORP BGKG6G7 20.34 112,703 2,292,379.02
2.62 4483 JP JMDC INC BK7C5Q9 37.17 61,372 2,281,479.29
2.57 MASI MASIMO CORP B1YWR63 95.41 23,487 2,240,894.67
2.56 COP GR COMPUGROUP MEDIC BMY7CH1 40.67 54,962 2,235,361.12
2.10 PHR PHREESIA INC BKF9DQ8 17.76 103,228 1,833,329.28
1.86 4480 JP MEDLEY INC BK93ZN7 32.75 49,505 1,621,361.04
1.73 HIMS HIMS & HERS HEALTH INC BN46048 6.01 250,348 1,504,591.48
1.44 LFST LIFESTANCE HEALT BN0TRB7 6.94 181,342 1,258,513.48
0.99 DCGO DOCGO INC BKP4P23 5.10 169,066 862,236.60
0.89 GDRX GOODRX HOLDIN-A BMTVQT8 5.58 138,899 775,056.42
0.73 4736 TT TAIDOC TECHNOLOGY CORP B3DBMV5 4.60 137,800 634,351.48
0.73 DH DEFINITIVE HEALT BMGSDK2 7.89 80,374 634,150.86
0.69 SHCR SHARECARE INC BJL95B4 0.91 663,201 600,528.51
0.63 FTRE FORTREA HOLDINGS INC BRXYZ57 27.78 19,804 550,155.12
0.59 ME 23ANDME HOLDIN-A BM9CKX3 1.00 514,158 514,158.00
0.58 AMWL AMERICAN WELL -A BN0SDK5 1.19 426,138 507,104.22
0.52 SENS SENSEONICS HOLDINGS INC BYQNYR5 0.52 861,331 452,026.51
0.48 CPSI COMPUTER PROGRAM 2872122 14.72 28,296 416,517.12
0.38 NVTA INVITAE CORP BVVCNT1 0.67 493,770 330,825.90
0.29 OPRX OPTIMIZERX CORP BF5MM09 7.52 33,483 251,792.16
0.21 BNGO BIONANO GENOMICS INC BQ9D250 2.92 61,393 179,266.98
0.06 OTHER PAYABLE & RECEIVABLES 1.00 55,271 55,271.36
0.04 CASH 1.00 31,055 31,054.93
0.00 AUSTRALIAN DOLLAR 0.65 1,977 1,276.94
0.00 HONG KONG DOLLAR 0.13 4 0.51
Holdings are subject to change. "Cash" denotes U.S. dollars.

Exposure As of 08/31/23

Sector Weight (%)
Health Care 93.8
Consumer Discretionary 3.4
Financials 1.5
Information Technology 0.8
Industrials 0.6

Source: new windowAltaVista Research, LLC

Industry Weight (%)
Medical Specialties 19.4
Information Technology Services 15.2
Biotechnology 14.8
Medical/Nursing Services 14.2
Miscellaneous Commercial Services 8.0
Services to the Health Industry 7.7
Internet Software/Services 5.9
Hospital/Nursing Management 4.5
Data Processing Services 4.4
Packaged Software 4.3
Financial Conglomerates 1.8

Source: new windowAltaVista Research, LLC

Country Weight (%)
United States 83.1
China 6.0
Japan 3.8
Hong Kong 3.7
Germany 2.6
Taiwan 0.8

Source: new windowAltaVista Research, LLC

All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.

ETF Characteristics As of 09/21/23

Return on Equity -5.20%
Weighted Avg. Market Cap 8,091 M
2022 2023
Price-to-earnings -4.96 -41.88
Price-to-book value 2.07 2.29

Source: new windowAltaVista Research, LLC

ETF Risk Stats As of 08/31/23

Versus Beta
S&P 500 0.91
NASDAQ-100 0.70
MSCI EAFE 0.89
MSCI Emg. Mkts 0.82
Standard Deviation 22.40%

Source: new windowAltaVista Research, LLC

ETF Research

View More Related Research

Investing involves risk, including the possible loss of principal. The investable universe of companies in which EDOC may invest may be limited. The Fund invests in securities of companies engaged in the Health Care and Information Technology sectors. These sectors can be affected by government regulations, rapid product obsolescence, intense industry competition and loss or impairment of patents or intellectual property rights. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. EDOC is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Solactive AG, nor does Solactive AG make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Solactive AG.